Klatskin Tumor
14
4
4
4
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
7.1%
1 terminated out of 14 trials
80.0%
-6.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (14)
Diagnostic Efficacy of EUS-FNA/B Versus ERCP With or Without POCS-TB in Patients With Suspected Hilar Cholangiocarcinoma
Liver Transplantation for Non-resectable Perihilar Cholangiocarcinoma
Stereotactic Body Radiation Therapy After Chemotherapy for Unresectable Perihilar Cholangiocarcinoma
Raman Spectroscopy in the Diagnosis of Extrahepatic Cholangiocarcinoma - a Pilot Study
Liver Transplantation for Unresectable Perihilar Cholangiocarcinoma
Endoscopic Radiofrequency Ablation for Unresectable Cholangiocarcinoma
Endoscopic Scissors Cutting Nasobiliary Duct VS Bilateral Plastic Stent
Safety and Tumoricidal Effect of Low Dose Foscan PDT in Patients With Inoperable Bile Duct Cancers
Application of Endoscopic Scissors Cutting ENBD Tube in the Treatment of Malignant Hilar Biliary Strictures
Stereotactic Body Radiation Therapy for Unresectable Perihilar Cholangiocarcinoma
Effectiveness of Prophylactic Antibiotics to Prevent Post Endoscopic Retrograde Cholangio Pancreatography Bacteremia in Biliary Obstruction Patient
Process Optimization of Preoperative Biliary Drainage in Patients With Malignant Obstructive Jaundice
Single Versus Multiple Deployment of Metallic Stents for Inoperable Malignant Hilar Biliary Obstruction
Cyberknife Radiosurgery Boost for Hilar Cholangiocarcinoma (Klatskin Tumor)